Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 13 studies | 23% ± 5% | |
brain | 8 studies | 38% ± 17% | |
lung | 7 studies | 23% ± 5% | |
eye | 5 studies | 25% ± 6% | |
bone marrow | 4 studies | 19% ± 3% | |
lymph node | 4 studies | 19% ± 3% | |
intestine | 4 studies | 22% ± 8% | |
liver | 4 studies | 33% ± 22% | |
uterus | 3 studies | 21% ± 5% | |
breast | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2867.29 | 2642 / 2642 | 100% | 29.14 | 705 / 705 |
esophagus | 100% | 2181.36 | 1445 / 1445 | 100% | 20.63 | 183 / 183 |
breast | 100% | 2728.31 | 459 / 459 | 100% | 21.73 | 1117 / 1118 |
lung | 100% | 2973.60 | 577 / 578 | 100% | 22.27 | 1155 / 1155 |
uterus | 100% | 3259.22 | 170 / 170 | 100% | 21.44 | 458 / 459 |
prostate | 100% | 2233.08 | 245 / 245 | 100% | 14.83 | 500 / 502 |
thymus | 100% | 2380.74 | 653 / 653 | 100% | 26.21 | 602 / 605 |
kidney | 100% | 1986.28 | 89 / 89 | 99% | 20.88 | 895 / 901 |
ovary | 100% | 4797.70 | 180 / 180 | 99% | 15.82 | 427 / 430 |
adrenal gland | 100% | 3438.42 | 258 / 258 | 99% | 22.83 | 228 / 230 |
bladder | 100% | 2341.00 | 21 / 21 | 99% | 17.30 | 498 / 504 |
stomach | 100% | 1616.12 | 359 / 359 | 99% | 16.50 | 282 / 286 |
intestine | 100% | 2462.10 | 966 / 966 | 97% | 16.23 | 513 / 527 |
skin | 100% | 1843.27 | 1804 / 1809 | 96% | 20.64 | 451 / 472 |
pancreas | 95% | 854.29 | 313 / 328 | 98% | 19.38 | 175 / 178 |
liver | 100% | 1172.61 | 226 / 226 | 92% | 9.04 | 375 / 406 |
adipose | 100% | 2938.02 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3035.44 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.30 | 29 / 29 |
spleen | 100% | 3168.27 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.32 | 45 / 45 |
muscle | 100% | 1500.13 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 100% | 1804.26 | 857 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 2351.30 | 905 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 78% | 11.11 | 62 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009611 | Biological process | response to wounding |
GO_0042060 | Biological process | wound healing |
GO_0005829 | Cellular component | cytosol |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FGFR1OP2 |
Protein name | FGFR1 oncogene partner 2 |
Synonyms | HSPC123 |
Description | FUNCTION: May be involved in wound healing pathway. . |
Accessions | ENST00000544111.5 ENST00000546072.5 [Q9NVK5-3] F5GX47 ENST00000327214.5 [Q9NVK5-2] Q9NVK5 ENST00000229395.8 [Q9NVK5-1] |